4.3 Review

Barriers to Optimal Hypertension Control

Journal

JOURNAL OF CLINICAL HYPERTENSION
Volume 10, Issue 8, Pages 644-646

Publisher

WILEY
DOI: 10.1111/j.1751-7176.2008.08329.x

Keywords

-

Funding

  1. National Heart, Lung, and Blood Institute [R01 HL078566]

Ask authors/readers for more resources

There is an obvious gap in the translation of clinical trial evidence into practice with regards to optimal hypertension control. The three major categories of barriers to BP control are patient-related, physician-related, and medical environment/health care system factors. Patient-related barriers include poor medication adherence, beliefs about hypertension and its treatment, depression, health literacy, comorbidity, and patient motivation. The most pertinent is medication adherence, given its centrality to the other factors. The most salient physician-related barrier is clinical inertia-defined, as the failure of health care providers to initiate or intensify drug therapy in a patient with uncontrolled BE The major reasons for clinical inertia are: 1) overestimation of the amount of care that physicians provide; 2) lack of training on bow to attain target BP levels; and 3) clinicians' use of soft reasons to avoid treatment intensification by adopting a wait until next visit approach in response to patients, excuses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available